Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Dexmedetomidine on Acute Renal Injury Patients Undergoing CABG
IRCT20251013067605N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine in acute kidney failure (AKF) and coronary arteriosclerosis, sponsored by Mashhad University of Medical Sciences. Started Nov 2025; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
acute kidney failure (AKF)coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20251013067605N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251013067605N1.